Tirdzniecība Recordati SPA - RECm CFD
Pievienot izlasei- Kopsavilkums
- Vēsturiskie Dati
- Notikumi
- Peļņas Atskaite
- Bilance
- Naudas Plūsma
- Īpašums
Tirdzniecības Nosacījumi
| Starpība | 0.14 | ||||||||
|
Garās pozīcijas nodeva naktij
Long position overnight fee
Doties uz platformu | -0.024161% | ||||||||
|
Īsās pozīcijas nodeva naktij
Short position overnight fee
Doties uz platformu | -0.020283% | ||||||||
| Nakts laika nodeva | 22:00 (UTC) | ||||||||
| Min. tirgotais daudzums | 1 | ||||||||
| Valūta | EUR | ||||||||
| Drošības rezerve | 20% | ||||||||
| Fondu birža | Italy | ||||||||
| Tirdzniecības komisija | 0% |
*Information provided by Capital.com
Recordati Industria Chimica e Farmaceutica SpA ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Galvenie Statistikas Dati
| Iepriekš. aizvērt* | 40.45 |
| Atvērt* | 40.46 |
| Izmaiņas par 1 gadu* | -14.53% |
| Dienas Diapazons* | 40.39 - 40.64 |
| 52 ned Diapazons | 34.52-49.83 |
| Vidējais apjoms (10 dienas) | 195.74K |
| Vidējais apjoms (3 mēneši) | 4.41M |
| Tirgus Kapitalizācija | 8.49B |
| Cenas/Peļņas Attiecība | 25.54 |
| Izvietotās Akcijas | 205.46M |
| Ieņēmumi | 1.80B |
| EPS | 1.59 |
| Dividende (Ienesīgums %) | 2.75726 |
| Beta | 0.18 |
| Nākamās Peļņas Datums | Feb 21, 2023 |
"Visus datus nodrošina Refinitiv, izņemot datus, kas atzīmēti ar zvaigznīti, kas ir *dati, kurus nodrošina Capital.com"
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Aizvēršana | Change | Change (%) | Atvēršana | High | Low |
|---|---|---|---|---|---|---|
| Feb 6, 2023 | 40.45 | 0.64 | 1.61% | 39.81 | 40.51 | 39.43 |
| Feb 3, 2023 | 40.13 | 0.45 | 1.13% | 39.68 | 40.34 | 39.41 |
| Feb 2, 2023 | 39.95 | 0.59 | 1.50% | 39.36 | 40.23 | 39.25 |
| Feb 1, 2023 | 39.13 | -0.96 | -2.39% | 40.09 | 40.22 | 38.87 |
| Jan 31, 2023 | 39.99 | -0.98 | -2.39% | 40.97 | 41.00 | 39.94 |
| Jan 30, 2023 | 41.24 | 0.87 | 2.16% | 40.37 | 41.30 | 40.32 |
| Jan 27, 2023 | 40.65 | 0.34 | 0.84% | 40.31 | 40.67 | 39.95 |
| Jan 26, 2023 | 40.54 | -0.66 | -1.60% | 41.20 | 41.43 | 40.45 |
| Jan 25, 2023 | 40.84 | -0.24 | -0.58% | 41.08 | 41.11 | 40.34 |
| Jan 24, 2023 | 41.30 | -0.17 | -0.41% | 41.47 | 41.61 | 41.06 |
| Jan 23, 2023 | 41.32 | -0.40 | -0.96% | 41.72 | 41.75 | 40.87 |
| Jan 20, 2023 | 41.62 | 0.01 | 0.02% | 41.61 | 42.13 | 41.50 |
| Jan 19, 2023 | 41.64 | -0.40 | -0.95% | 42.04 | 42.32 | 41.54 |
| Jan 18, 2023 | 42.01 | 0.35 | 0.84% | 41.66 | 42.31 | 41.44 |
| Jan 17, 2023 | 41.83 | 1.40 | 3.46% | 40.43 | 41.96 | 39.95 |
| Jan 16, 2023 | 40.03 | -0.12 | -0.30% | 40.15 | 40.31 | 39.92 |
| Jan 13, 2023 | 40.05 | 0.66 | 1.68% | 39.39 | 40.26 | 39.35 |
| Jan 12, 2023 | 39.19 | 0.53 | 1.37% | 38.66 | 39.23 | 38.59 |
| Jan 11, 2023 | 38.78 | -0.21 | -0.54% | 38.99 | 39.20 | 38.75 |
| Jan 10, 2023 | 39.01 | 0.20 | 0.52% | 38.81 | 39.27 | 38.77 |
Recordati SPA Events
| Time (UTC) | Country | Event |
|---|---|---|
| No events scheduled | ||
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Kopējie ienākumi | 1153.94 | 1288.12 | 1352.23 | 1481.85 | 1448.87 | 1580.07 |
| Ienākumi | 1153.94 | 1288.12 | 1352.23 | 1481.85 | 1448.87 | 1580.07 |
| Cost of Revenue, Total | 360.959 | 382.754 | 395.569 | 436.901 | 406.831 | 427.727 |
| Bruto Peļņa | 792.983 | 905.369 | 956.666 | 1044.95 | 1042.04 | 1152.35 |
| Kopējie Darbības Izdevumi | 826.519 | 881.631 | 910.016 | 1016.58 | 979.851 | 1089.88 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 369.219 | 396.375 | 401.219 | 445.586 | 421.857 | 480.889 |
| Pētniecība un Attīstība | 83.71 | 100.256 | 67.093 | 77.081 | 146.236 | 166.138 |
| Neparedzēti Izdevumi (Ienākumi) | 12.631 | 2.246 | 3.535 | 0.264 | 4.927 | 14.478 |
| Darbības Izdevumi | 327.423 | 406.492 | 442.219 | 465.266 | 469.016 | 490.19 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -9.866 | -17.148 | -17.977 | -20.616 | -13.203 | -26.718 |
| Citi, Neto | -0.275 | -0.229 | -6.307 | -0.506 | -0.157 | -0.123 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | 317.282 | 389.115 | 417.935 | 444.144 | 455.656 | 463.349 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 237.431 | 288.799 | 312.422 | 368.866 | 355.027 | 385.966 |
| Mazākuma Interese | -0.025 | -0.037 | -0.046 | -0.041 | -0.043 | 0 |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
| Neto Ienākumi | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 237.406 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
| Atšķaidīšanas Iestāstīšana | 0.025 | |||||
| Atšķaidītie Neto Ienākumi | 237.431 | 288.762 | 312.376 | 368.825 | 354.984 | 385.966 |
| Atšķaidītie Ienākumi par Akcijām | 209.19 | 209.096 | 209.087 | 209.084 | 209.06 | 209.082 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 1.135 | 1.381 | 1.494 | 1.764 | 1.698 | 1.846 |
| Dividends per Share - Common Stock Primary Issue | 0.7 | 0.85 | 0.92 | 1 | 1.05 | 1.1 |
| Atšķaidītā Normalizētā Peļņa par Akciju | 1.18018 | 1.38897 | 1.50664 | 1.76505 | 1.7131 | 1.89642 |
| Depreciation / Amortization | 42.6 | 52.6 | ||||
| Other Operating Expenses, Total | 4.15 | 0 | 0.652 |
| Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
|---|---|---|---|---|---|
| Kopējie ienākumi | 384.838 | 385.997 | 385.354 | 423.885 | 419.381 |
| Ienākumi | 384.838 | 385.997 | 385.354 | 423.885 | 419.381 |
| Cost of Revenue, Total | 104.069 | 101.871 | 107.065 | 114.722 | 115.478 |
| Bruto Peļņa | 280.769 | 284.126 | 278.289 | 309.163 | 303.903 |
| Kopējie Darbības Izdevumi | 259.951 | 260.516 | 262.795 | 306.622 | 288.11 |
| Pārdošanas/Vispārīgi/Admin. Izdevumi, Kopā | 113.409 | 117.419 | 116.236 | 133.825 | 121.733 |
| Pētniecība un Attīstība | 41.456 | 39.673 | 38.562 | 46.447 | 43.669 |
| Neparedzēti Izdevumi (Ienākumi) | 0.774 | 0.561 | 0.487 | 12.656 | 7.115 |
| Other Operating Expenses, Total | 0.243 | 0.992 | 0.445 | -1.028 | 0.115 |
| Darbības Izdevumi | 124.887 | 125.481 | 122.559 | 117.263 | 131.271 |
| Ienākumi no Procentiem (Izdevumi), Neto, ar Darbību Nesaistītie | -8.883 | -5.964 | -7.313 | -4.558 | -6.926 |
| Citi, Neto | -0.01 | -0.011 | -0.01 | -0.092 | -0.027 |
| Neto Ienākumi Pirms Nodokļu Nomaksas | 115.994 | 119.506 | 115.236 | 112.613 | 124.318 |
| Neto Ienākumi Pēc Nodokļu Nomaksas | 89.884 | 117.222 | 89.28 | 89.58 | 96.72 |
| Mazākuma Interese | -0.012 | -0.01 | 0.022 | 0 | |
| Neto Ienākumi Pirms Ārkārtas Posteņiem | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
| Neto Ienākumi | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
| Kopējie Ienākumi, Izņemot Ārkārtas Posteņus | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
| Kopējie Ienākumi, Ieskaitot Ārkārtas Posteņus | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
| Atšķaidītie Neto Ienākumi | 89.872 | 117.212 | 89.302 | 89.58 | 96.72 |
| Atšķaidītie Ienākumi par Akcijām | 209.005 | 209.347 | 209.142 | 208.836 | 209.351 |
| Atšķaidītie Ienākumi, Izņemot Ārkārtas Posteņus | 0.43 | 0.55989 | 0.42699 | 0.42895 | 0.462 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0.53 | 0 | 0.57 | 0 |
| Atšķaidītā Normalizētā Peļņa par Akciju | 0.43 | 0.55874 | 0.42699 | 0.48058 | 0.48849 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 552.233 | 773.685 | 699.931 | 809.35 | 772.951 | 850.101 |
| Nauda un Īstermiņa Ieguldījumi | 138.493 | 302.077 | 198.036 | 187.923 | 188.23 | 244.578 |
| Cash | 117.17 | 273.343 | 172.421 | 141.384 | 175.227 | 230.924 |
| Nauda un Ekvivalenti | 21.323 | 28.734 | 25.615 | 46.539 | 13.003 | 13.654 |
| Debitoru Parādu Kopsumma, Neto | 228.9 | 282.478 | 281.276 | 374.328 | 313.859 | 350.335 |
| Accounts Receivable - Trade, Net | 205.988 | 244.117 | 245.742 | 296.961 | 268.897 | 307.778 |
| Total Inventory | 158.8 | 179.1 | 206.084 | 226.885 | 251.252 | 228.732 |
| Prepaid Expenses | 8.062 | 6.205 | 8.121 | 10.265 | 12.574 | 15.307 |
| Other Current Assets, Total | 17.978 | 3.825 | 6.414 | 9.949 | 7.036 | 11.149 |
| Total Assets | 1560.74 | 2056.41 | 2161.26 | 2808.93 | 2711.65 | 2816.2 |
| Property/Plant/Equipment, Total - Net | 110.202 | 103.009 | 103.582 | 133.342 | 133.25 | 131.12 |
| Property/Plant/Equipment, Total - Gross | 374.684 | 376.699 | 387.858 | 437.716 | 453.036 | 462.825 |
| Accumulated Depreciation, Total | -264.482 | -273.69 | -284.276 | -304.374 | -319.786 | -331.705 |
| Goodwill, Net | 556.566 | 539.871 | 577.786 | 577.973 | 562.116 | 553.209 |
| Intangibles, Net | 279.884 | 540.565 | 672.106 | 1161.76 | 1115.81 | 1138.79 |
| Long Term Investments | 19.199 | 24.171 | 20.773 | 38.566 | 45.581 | 34.124 |
| Other Long Term Assets, Total | 42.659 | 75.106 | 87.087 | 87.939 | 81.945 | 108.859 |
| Total Current Liabilities | 311.31 | 375.546 | 490.742 | 586.754 | 578.464 | 626.416 |
| Accounts Payable | 124.644 | 141.74 | 165.02 | 175.481 | 132.096 | 177.925 |
| Accrued Expenses | 42.807 | 43.68 | 42.289 | 45.267 | 39.649 | 56.191 |
| Notes Payable/Short Term Debt | 15.689 | 16.577 | 16.905 | 13.392 | 12.567 | 8.657 |
| Current Port. of LT Debt/Capital Leases | 40.428 | 51.71 | 130.583 | 149.817 | 270.254 | 223.061 |
| Other Current Liabilities, Total | 87.742 | 121.839 | 135.945 | 202.797 | 123.898 | 160.582 |
| Total Liabilities | 656.913 | 1029.32 | 1197.87 | 1610.35 | 1435.67 | 1434.57 |
| Total Long Term Debt | 293.644 | 612.462 | 640.647 | 937.344 | 778.238 | 760.473 |
| Long Term Debt | 293.644 | 612.462 | 640.647 | 937.344 | 760.587 | 745.382 |
| Deferred Income Tax | 27.659 | 17.554 | 43.486 | 43.172 | 41.219 | 26.675 |
| Minority Interest | 0.11 | 0.147 | 0.193 | 0.234 | 0.277 | 0 |
| Other Liabilities, Total | 24.19 | 23.608 | 22.804 | 42.849 | 37.473 | 21.01 |
| Total Equity | 903.83 | 1027.09 | 963.393 | 1198.58 | 1275.98 | 1381.62 |
| Common Stock | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 |
| Additional Paid-In Capital | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 |
| Retained Earnings (Accumulated Deficit) | 956.46 | 1064.13 | 1161.69 | 1334.42 | 1473.6 | 1612.81 |
| Treasury Stock - Common | -76.761 | -17.029 | -145.608 | -93.48 | -87.516 | -126.981 |
| Other Equity, Total | -85.729 | -129.871 | -162.545 | -152.223 | -219.962 | -214.06 |
| Total Liabilities & Shareholders’ Equity | 1560.74 | 2056.41 | 2161.26 | 2808.93 | 2711.65 | 2816.2 |
| Total Common Shares Outstanding | 205.234 | 208.262 | 204.379 | 204.959 | 206.296 | 205.911 |
| Capital Lease Obligations | 17.651 | 15.091 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Apgrozāmo Līdzekļu Kopsumma | 861.321 | 907.382 | 958.115 | 850.101 | 961.621 |
| Nauda un Īstermiņa Ieguldījumi | 250.085 | 271.869 | 341.926 | 244.578 | 261.43 |
| Nauda un Ekvivalenti | 250.085 | 271.869 | 341.926 | 244.578 | 261.43 |
| Debitoru Parādu Kopsumma, Neto | 343.118 | 357.259 | 345.649 | 352.658 | 407.68 |
| Accounts Receivable - Trade, Net | 307.91 | 304.542 | 300.769 | 307.778 | 367.012 |
| Total Inventory | 243.684 | 257 | 244.501 | 228.732 | 256.489 |
| Other Current Assets, Total | 24.434 | 9.067 | 26.039 | 11.149 | 36.022 |
| Total Assets | 2837.47 | 2875.92 | 2929.54 | 2816.2 | 3642.95 |
| Property/Plant/Equipment, Total - Net | 131.384 | 130.9 | 132.992 | 131.12 | 129.207 |
| Property/Plant/Equipment, Total - Gross | 455.542 | 458.108 | 464.546 | 462.825 | 464.469 |
| Accumulated Depreciation, Total | -324.158 | -327.208 | -331.554 | -331.705 | -335.262 |
| Goodwill, Net | 560.466 | 559.899 | 560.309 | 553.209 | 1125.12 |
| Intangibles, Net | 1143.84 | 1132.93 | 1128.04 | 1138.79 | 1292.75 |
| Long Term Investments | 47.405 | 39.672 | 41.963 | 34.124 | 23.34 |
| Other Long Term Assets, Total | 93.055 | 105.135 | 108.13 | 108.859 | 110.922 |
| Total Current Liabilities | 628.61 | 586.368 | 610.638 | 626.416 | 725.019 |
| Accounts Payable | 145.065 | 160.355 | 166.917 | 177.925 | 194.998 |
| Notes Payable/Short Term Debt | 35.997 | 29.106 | 13.478 | 8.657 | 15.022 |
| Current Port. of LT Debt/Capital Leases | 275.06 | 222.805 | 228.168 | 223.061 | 252.279 |
| Other Current Liabilities, Total | 172.488 | 174.102 | 202.075 | 216.773 | 262.72 |
| Total Liabilities | 1508.69 | 1547.83 | 1484.48 | 1434.57 | 2193.52 |
| Total Long Term Debt | 800.325 | 895.648 | 824.701 | 760.473 | 1403.58 |
| Long Term Debt | 800.325 | 879.552 | 808.965 | 745.382 | 1389.77 |
| Deferred Income Tax | 41.11 | 27.17 | 27.787 | 26.675 | 26.909 |
| Minority Interest | 0.289 | 0.299 | 0 | 0 | 0 |
| Other Liabilities, Total | 38.354 | 38.343 | 21.351 | 21.01 | 38.015 |
| Total Equity | 1328.78 | 1328.09 | 1445.07 | 1381.62 | 1449.43 |
| Common Stock | 26.141 | 26.141 | 26.141 | 26.141 | 26.141 |
| Additional Paid-In Capital | 83.719 | 83.719 | 83.719 | 83.719 | 83.719 |
| Retained Earnings (Accumulated Deficit) | 1562.21 | 1552.6 | 1640.89 | 1612.81 | 1699.78 |
| Treasury Stock - Common | -126.637 | -115.257 | -98.924 | -126.981 | -144.381 |
| Other Equity, Total | -216.649 | -219.116 | -206.753 | -214.06 | -215.826 |
| Total Liabilities & Shareholders’ Equity | 2837.47 | 2875.92 | 2929.54 | 2816.2 | 3642.95 |
| Total Common Shares Outstanding | 205.479 | 205.909 | 206.365 | 205.911 | 205.587 |
| Prepaid Expenses | 12.187 | 12.984 | |||
| Capital Lease Obligations | 16.096 | 15.736 | 15.091 | 13.81 |
- Ikgadējs
- Ceturkšņa
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|---|
| Neto ienākumi/Sākuma Līnija | 237.431 | 288.799 | 312.422 | 368.866 | 355.027 | 385.966 |
| Nauda no Darbības | 255.436 | 272.711 | 357.838 | 318.7 | 403.575 | 492.129 |
| Nauda no Darbības | 12.466 | 14.186 | 13.901 | 25.17 | 25.355 | 25.294 |
| Amortization | 25.466 | 33.967 | 42.959 | 53.078 | 68.317 | 72.291 |
| Deferred Taxes | -5.637 | -32.422 | -6.637 | |||
| Bezskaidras Naudas Preces | 6.919 | -11.407 | 4.697 | 102.747 | 124.979 | 113.194 |
| Izmaiņas Apgrozāmajā Kapitālā | -21.209 | -20.412 | -9.504 | -231.161 | -170.103 | -104.616 |
| Nauda no Ieguldījumu Darbībām | -158.489 | -321.188 | -231.778 | -441.209 | -131.555 | -87.499 |
| Kapitālie Izdevumi | -19.669 | -14.588 | -19.362 | -443.288 | -131.678 | -87.36 |
| Citi Ieguldījumu Naudas Plūsmas Posteņi, Kopā | -138.82 | -306.6 | -212.416 | 2.079 | 0.123 | -0.139 |
| Nauda no Darbībām ar Finansēšanu | -189.819 | 224.656 | -224.688 | 109.526 | -264.288 | -355.943 |
| Naudas Plūsma Finansēšanas Posteņos | -1.679 | 3.716 | 0.439 | -2.19 | 1.74 | |
| Total Cash Dividends Paid | -133.73 | -159.607 | -178.887 | -190.916 | -212.718 | -216.742 |
| Akciju Izsniegšana (Atkāpšanās), Neto | -48.886 | 30.267 | -149.552 | 26.187 | -12.17 | -59.308 |
| Parādu Izsniegšana (Atkāpšanās), Neto | -5.524 | 350.28 | 103.312 | 276.445 | -41.14 | -79.893 |
| Neto Izmaiņas Naudā | -92.872 | 162.696 | -104.369 | -10.113 | 0.307 | 56.348 |
| Ārvalstu Valūtas Ietekme | -13.483 | -5.741 | 2.87 | -7.425 | 7.661 | |
| Cash Taxes Paid | 140.14 | 65.272 | 91.646 | |||
| Samaksātie Procenti Naudā | 17.597 | 18.699 | 18.279 |
| Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | 89.884 | 207.106 | 296.386 | 385.966 | 96.72 |
| Cash From Operating Activities | 114.135 | 213.826 | 368.622 | 492.129 | 113.431 |
| Cash From Operating Activities | 6.311 | 12.633 | 18.928 | 25.294 | 6.016 |
| Amortization | 18.049 | 35.873 | 53.968 | 72.291 | 18.635 |
| Non-Cash Items | 31.74 | 40.95 | 73.508 | 113.194 | 35.714 |
| Cash Taxes Paid | 6.302 | 46.563 | 61.599 | 91.646 | 10.653 |
| Cash Interest Paid | 2.243 | 9.147 | 11.476 | 18.279 | 2.344 |
| Changes in Working Capital | -31.849 | -82.736 | -74.168 | -104.616 | -43.654 |
| Cash From Investing Activities | -57.132 | -66.56 | -76.89 | -87.499 | -722.27 |
| Capital Expenditures | -57.317 | -66.718 | -76.744 | -87.36 | -15.599 |
| Other Investing Cash Flow Items, Total | 0.185 | 0.158 | -0.146 | -0.139 | -706.671 |
| Cash From Financing Activities | 1.754 | -66.585 | -143.698 | -355.943 | 571.438 |
| Total Cash Dividends Paid | -0.74 | -108.699 | -109.389 | -216.742 | -6.219 |
| Issuance (Retirement) of Stock, Net | -43.227 | -40.458 | -29.028 | -59.308 | -18.383 |
| Issuance (Retirement) of Debt, Net | 45.721 | 82.572 | -5.281 | -79.893 | 596.04 |
| Foreign Exchange Effects | 3.098 | 2.958 | 5.662 | 7.661 | 1.018 |
| Net Change in Cash | 61.855 | 83.639 | 153.696 | 56.348 | -36.383 |
| Investora vārds | Investora veids | Nenokārtots procents | Akcijas turējumā | Izmaiņas akcijās | Turēšanas termiņš | Apgrozījuma reitings |
|---|---|---|---|---|---|---|
| Fimei Finanziaria Industriale Mobiliare Ed Immobiliare SpA | Holding Company | 51.82 | 108368656 | 0 | 2023-01-04 | LOW |
| Mawer Investment Management Ltd. | Investment Advisor | 4.997 | 10449984 | -43916 | 2022-12-07 | LOW |
| Fidelity Management & Research Company LLC | Investment Advisor | 3.402 | 7114438 | 0 | 2023-01-04 | LOW |
| FMR Investment Management (U.K.) Limited | Investment Advisor | 1.7855 | 3733978 | -13156 | 2022-12-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.3647 | 2853934 | 21111 | 2022-12-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2698 | 2655430 | -21481 | 2023-01-31 | LOW |
| Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.968 | 2024252 | 293858 | 2022-12-31 | LOW |
| La Financière de l'Echiquier | Investment Advisor | 0.618 | 1292377 | 40 | 2022-11-30 | MED |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.5221 | 1091897 | 5 | 2023-01-31 | LOW |
| BlackRock Advisors (UK) Limited | Investment Advisor/Hedge Fund | 0.451 | 943207 | -6025 | 2022-12-31 | LOW |
| Manulife Investment Management (North America) Limited | Investment Advisor | 0.4196 | 877523 | 17954 | 2022-11-30 | LOW |
| Invesco Advisers, Inc. | Investment Advisor | 0.405 | 846946 | 66300 | 2022-12-31 | LOW |
| California Public Employees' Retirement System | Pension Fund | 0.371 | 775787 | -99342 | 2021-06-30 | LOW |
| Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 0.3659 | 765091 | 519 | 2022-12-31 | HIGH |
| State Street Global Advisors (UK) Ltd. | Investment Advisor/Hedge Fund | 0.361 | 754985 | -23096 | 2022-12-31 | LOW |
| TD Asset Management Inc. | Investment Advisor | 0.3407 | 712591 | 1039 | 2022-12-31 | LOW |
| Epoch Investment Partners, Inc. | Investment Advisor | 0.331 | 692301 | -46 | 2022-12-31 | LOW |
| Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 0.3308 | 691687 | -643 | 2022-12-31 | LOW |
| Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.2699 | 564365 | 346 | 2023-01-31 | LOW |
| Caisse de Depot et Placement du Quebec | Pension Fund | 0.2663 | 556837 | 450028 | 2021-12-31 | LOW |
Kāpēc izvēlēties Capital.com? Mūsu skaitļi runā paši par sevi.
Capital.com Group +485000+
Tirgotāji
65000+
Ikmēneša aktīvie klienti
$48000000+
Ikmēneša ieguldījumu apjoms
$28000000+
Izmēģināt tagad Izņemts katru mēnesi
Treidinga kalkulators
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Tirdzniecības komisija
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
Finanšu svira
20:1
- 20
- 100
- 500
- 1000
- 10000
Investīcija
Darījuma apjoms (Kredītplecs x Investīcija):
Atvēršana
Aizvēršana
Īss Garšs
Recordati Company profile
Par Recordati SPA
Recordati Industria Chimica e Farmaceutica SpA ir Itālijā bāzēta grupa, kas nodarbojas ar farmaceitisko līdzekļu pētniecību, izstrādi, ražošanu un tirdzniecību. Tā popularizē plašu farmācijas produktu klāstu, gan patentētu, gan licencētu, vairākās terapeitiskās jomās, piemēram, antibiotikas un pretvīrusu, sirds un asinsvadu, centrālās nervu sistēmas, dermatoloģijas, gastroenteroloģijas, dzimumorgānu un urīnceļu sistēmas, muskuļu un skeleta sistēmas traucējumu un sāpju terapijas, dzemdniecības un ginekoloģijas, kā arī bezrecepšu (OTC) farmācijas produktu jomā. Uzņēmums nodarbojas ar jaunu zāļu vienību izpēti un izstrādi kardiovaskulārās un uroģenitālās terapijas jomās, kā arī ar reto slimību ārstēšanu. Tā produkts ir ZANIDIP, jaunākās paaudzes kalcija kanālu blokators hipertensijas ārstēšanai. Uzņēmums darbojas, izmantojot Italchimici SpA, Pro Farma AG un Ziemeļamerikas tirdzniecības tiesības uz Cystadane. Uzņēmumam pieder Natural Point srl, kas darbojas arī uztura bagātinātāju nozarē.
| Industry: | Pharmaceuticals (NEC) |
Via M. Civitali, 1
MILANO
MILANO 20148
IT
Peļņas Atskaite
- Annual
- Quarterly
Cilvēki arī skatās
Vai joprojām meklējat mākleri, kuram varat uzticēties?
Pievienojieties 485 000+ tirgotājiem visā pasaulē, kuri izvēlējās tirgoties ar Capital.com